Velik Lazarov
Velik Lazarov has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Tsvetelina Velikova
Medical Faculty, Sofia University St. Kliment Ohridski, Sofia 1407, Bulgaria
2 shared publicationsDimitrina Georgieva Miteva
Medical Faculty, Sofia University St. Kliment Ohridski, Sofia 1407, Bulgaria
1 shared publicationEmilia Naseva
Faculty of Public Health, Medical University of Sofia, Sofia 1431, Bulgaria
1 shared publication- Issa El Kaouri
Faculty of Medicine, Medical University Sofia, Boulevard ‘Akademik Ivan Evstratiev Geshov’ 15, 1431 Sofia, Bulgaria
1 shared publication - Ivan Padjen
University of Zagreb, Zagreb, Croatia
1 shared publication - Konstantina Bakopoulou
Faculty of Medicine, Medical University Sofia, Boulevard ‘Akademik Ivan Evstratiev Geshov’ 15, 1431 Sofia, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 18 September 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 15 (3) , 103958
Advances in fertility preservation and pregnancy care for transplant patients
Fertility preservation and pregnancymanagement are critical considerations for patients undergoing organtransplantation. Innovations in assisted reproductive technologies, hormonalmodulation, and personalized medicine have expanded options for these patients, who face unique challenges due to immunosuppressive therapy and organ functionconcerns. This mini-review explores advancements in cryopreservationtechniques, pre-conception counseling, and multidisciplinary strategies forsafe pregnancies post-transplantation. Emphasis is placed on balancing maternalhealth, graft function, and fetal outcomes. The integration of reproductive andtransplant medicine is paving the way for improved quality of life andreproductive autonomy for this patient population.
- 18 September 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 15 (3) , 103958
Open AccessAdvances in fertility preservation and pregnancy care for transplant patients
Fertility preservation and pregnancymanagement are critical considerations for patients undergoing organtransplantation. Innovations in assisted reproductive technologies, hormonalmodulation, and personalized medicine have expanded options for these patients, who face unique challenges due to immunosuppressive therapy and organ functionconcerns. This mini-review explores advancements in cryopreservationtechniques, pre-conception counseling, and multidisciplinary strategies forsafe pregnancies post-transplantation. Emphasis is placed on balancing maternalhealth, graft function, and fetal outcomes. The integration of reproductive andtransplant medicine is paving the way for improved quality of life andreproductive autonomy for this patient population.
- Open Access
- 21 November 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 30 (43) , 4677-4681
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin
Despite advancements in the field, early diagnosis of multiple endocrine neoplasia type 1 (MEN1) remains unachievable. This letter to the editor highlighted the importance of carefully assessing gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin levels, as suggested by Yuan et al in their paper. They focused on a patient with recurrent abdominal pain and diarrhea whose diagnostic path led to establishing a MEN1 diagnosis within a year. This emphasized the need for clinicians to consider MEN1 in patients with similar presentations, particularly when gastrointestinal symptoms persist or recur after discontinuation of proton pump inhibitors, especially knowing that early recognition and intervention are crucial for improving patient outcomes.
- 21 November 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 30 (43) , 4677-4681
Open AccessImproving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin
Despite advancements in the field, early diagnosis of multiple endocrine neoplasia type 1 (MEN1) remains unachievable. This letter to the editor highlighted the importance of carefully assessing gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin levels, as suggested by Yuan et al in their paper. They focused on a patient with recurrent abdominal pain and diarrhea whose diagnostic path led to establishing a MEN1 diagnosis within a year. This emphasized the need for clinicians to consider MEN1 in patients with similar presentations, particularly when gastrointestinal symptoms persist or recur after discontinuation of proton pump inhibitors, especially knowing that early recognition and intervention are crucial for improving patient outcomes.
- Open Access
Lung Involvement in Systemic Sclerosis—From Pathogenesis to Prediction
Systemic sclerosis (SSc) is a rare, multifactorial autoimmune disease characterized by widespread vascular damage and fibrosis. Pulmonary involvement is a significant manifestation of SSc, contributing to considerable morbidity and mortality. Therefore, identifying reliable biomarkers is of the utmost importance. This review explores emerging biomarkers to enhance diagnostic accuracy, prognostic assessment, and disease monitoring in SSc lung involvement. We discuss recent findings in immunological biomarkers, inflammatory indicators, and other parameters that can function as potential diagnostic and prognostic tools. A comprehensive understanding of these biomarkers could result in earlier and more accurate detection of pulmonary complications in SSc, aiding in timely intervention. Furthermore, we explore the advances in disease monitoring through innovative biomarkers, focusing on their roles in disease activity and treatment response. Integrating these novel biomarkers into current clinical practice and therapeutic protocols through clinical trials can revolutionize the management of SSc-related lung disease, ultimately improving patient outcomes and quality of life.
Open AccessLung Involvement in Systemic Sclerosis—From Pathogenesis to Prediction
Systemic sclerosis (SSc) is a rare, multifactorial autoimmune disease characterized by widespread vascular damage and fibrosis. Pulmonary involvement is a significant manifestation of SSc, contributing to considerable morbidity and mortality. Therefore, identifying reliable biomarkers is of the utmost importance. This review explores emerging biomarkers to enhance diagnostic accuracy, prognostic assessment, and disease monitoring in SSc lung involvement. We discuss recent findings in immunological biomarkers, inflammatory indicators, and other parameters that can function as potential diagnostic and prognostic tools. A comprehensive understanding of these biomarkers could result in earlier and more accurate detection of pulmonary complications in SSc, aiding in timely intervention. Furthermore, we explore the advances in disease monitoring through innovative biomarkers, focusing on their roles in disease activity and treatment response. Integrating these novel biomarkers into current clinical practice and therapeutic protocols through clinical trials can revolutionize the management of SSc-related lung disease, ultimately improving patient outcomes and quality of life.